You're reading the free version. Trader adds the live tape and alerts.
Start tracking
KROS Buy Disclosure
Bien AI Me Jean Jacques · SEC Form 4 · Filed Jul 17, 2026
Buy
Calculated transaction value
$10.61K
Bien AI Me Jean Jacques Director
KROS
Keros Therapeutics
KROS
Transaction date
Jul 15, 2026
Public filing date
Jul 17, 2026
Filing lag
Filed 2 days later
KROS daily price context
Close on/before transaction
$11.03
Jul 15, 2026
First close after public filing
$10.61
Jul 20, 2026
30-day return after filing
-1.23%
Through Aug 17, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,000 shares @ $10.61
- SEC ownership
- Direct
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001221590-26-000023
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$10.61K
Buys / sales
1 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Keros Therapeutics, Inc. KROS Current | Buy | Jul 15, 2026 | $10.61K |